Ascendis Pharma A (ASND) Change in Cash (2014 - 2026)

Ascendis Pharma A (ASND) has 13 years of Change in Cash data on file, last reported at -$60.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 72.83% year-over-year to -$60.1 million; the trailing twelve-month figure through Mar 2026 stood at $73.9 million (down 66.77% YoY), and the FY2025 full-year result was $95.1 million, down 58.51% from the prior year.
• Change in Cash eased to -$60.1 million in Q1 2026, from $91.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $848.1 million in Q1 2022 to a low of -$118.1 million in Q2 2023.
• A 5-year average of $70.3 million and a median of -$20.0 million in 2025 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 816.62% in 2024, while the deepest fall reached 222.3% in 2024.
• Tracing ASND's Change in Cash over 5 years: stood at -$64.6 million in 2022, then surged by 168.87% to $44.5 million in 2023, then surged by 816.62% to $407.7 million in 2024, then slumped by 77.58% to $91.4 million in 2025, then tumbled by 165.72% to -$60.1 million in 2026.
• Business Quant data shows ASND's Change in Cash at -$60.1 million in Q1 2026, $91.4 million in Q4 2025, and $47.9 million in Q3 2025.